Argenx
ARGX
#631
Rank
ยฃ24.57 B
Marketcap
ยฃ405.37
Share price
0.56%
Change (1 day)
-4.03%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -ยฃ3.35

According to Argenx 's latest financial reports the company's current EPS (TTM) is -ยฃ3.17. In 2022 the company made an earnings per share (EPS) of -ยฃ10.00.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ3.35-66.45%
2022-ยฃ10.00